Synerkine Pharma

About:

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

Website: https://www.synerkinepharma.com/

Top Investors: InnovationQuarter, Thuja Capital, Netherlands Enterprise Agency, Flerie Invest, Utrecht Holdings

Description:

Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory mechanisms in different types of chronic pain and has unique properties, enabling patients to effectively reduce pain in multiple pre-clinical models.

Total Funding Amount:

12.1M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Utrecht, Utrecht, The Netherlands

Founded Date:

2009-01-01

Founders:

Hans Preusting

Number of Employees:

1-10

Last Funding Date:

2023-10-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai